CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Calcium patents expire, and when can generic versions of Calcium launch?
Calcium is a drug marketed by Amneal Pharms, Chartwell Rx, Heritage Pharms Inc, Hikma, Invagen Pharms, Lotus Pharm Co Ltd, Lupin, Mpp Pharma, Square Pharms, Suven Pharms, Chartwell Molecular, Padagis Us, Am Regent, Amneal, Extrovis, Intl Medication Sys, Medefil Inc, Somerset, Square Pharms Plc, Hospira, Bausch, Abbott, Abraxis Pharm, Lilly, B Braun Medical, Caplin, Fresenius Kabi Usa, Hq Spclt Pharma, Nivagen Pharms Inc, and Sagent. and is included in thirty-six NDAs. There are two patents protecting this drug.
The generic ingredient in CALCIUM is calcium gluconate. There are five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium
A generic version of CALCIUM was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CALCIUM?
- What are the global sales for CALCIUM?
- What is Average Wholesale Price for CALCIUM?
Summary for CALCIUM
| US Patents: | 0 |
| Applicants: | 30 |
| NDAs: | 36 |
| Drug Prices: | Drug price information for CALCIUM |
| Drug Sales Revenues: | Drug sales revenues for CALCIUM |
| DailyMed Link: | CALCIUM at DailyMed |
US Patents and Regulatory Information for CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nivagen Pharms Inc | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 213071-002 | Oct 19, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| B Braun Medical | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 216541-001 | Aug 21, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hq Spclt Pharma | CALCIUM GLUCONATE IN SODIUM CHLORIDE | calcium gluconate | SOLUTION;INTRAVENOUS | 210906-001 | Oct 29, 2018 | RX | Yes | Yes | 10,130,646 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
